Argenx Se (ARGX) Net Margin (2016 - 2026)
Argenx Se's (ARGX) quarterly Net Margin came in at 30.33% in Q2 2026, up 447.0% YoY from 5.55% in Q2 2025, and up 7.58% on a QoQ basis from 28.2% in Q1 2026.
Analysis
Argenx Se (ARGX) Net Margin (2016 - 2026) Analysis & Trends
Argenx Se (ARGX) has 11 years of Net Margin data on file, last reported at 30.33% in Q2 2026.
- Quarterly Net Margin rose 447.0% year-over-year to 30.33% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 32.57% (down 942.0% YoY) and the FY2025 annual result came in at 30.41%, down 658.0% from the prior year.
- Net Margin rose to 30.33% in Q2 2026, from 28.2% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 1073.51% in Q1 2022 to a low of 178.97% in Q3 2022.
- A 5-year average of 84.0% and a median of 24.07% in 2022 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin jumped 110012 bps — and 2023, when it slumped 106026 bps.
- Tracing ARGX's Net Margin over 5 years: stood at 22.27% in 2022, then advanced by 19 bps to 26.49% in 2023, then soared by 297 bps to 105.05% in 2024, then slumped by 61 bps to 41.45% in 2025, then retreated by 27 bps to 30.33% in 2026.
- The last three Net Margin figures came in at 30.33% (Q2 2026), 28.2% (Q1 2026), and 41.45% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -3.12% |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | 34.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.16% |
| Mar 31, 2026 | 28.20% |
| Dec 31, 2025 | 41.45% |
| Sep 30, 2025 | 30.55% |
| Jun 30, 2025 | 25.87% |
| Mar 31, 2025 | 21.39% |
| Dec 31, 2024 | 105.05% |
| Sep 30, 2024 | 15.95% |
| Jun 30, 2024 | 6.09% |
| Mar 31, 2024 | -15.47% |
| Dec 31, 2023 | -26.49% |
| Sep 30, 2023 | -22.07% |
| Jun 30, 2023 | -35.04% |
| Mar 31, 2023 | -13.24% |
| Dec 31, 2022 | -22.27% |
| Sep 30, 2022 | -178.97% |
| Jun 30, 2022 | -278.95% |
| Mar 31, 2022 | -1,073.51% |
| Dec 31, 2021 | -913.91% |
| Sep 30, 2021 | -27,259.51% |